Background: Malaria is a major cause of morbidity and mortality in the developing countries. Rational use of antimalarial drugs reduces the development of drug resistance and cost of therapy. Hence, we sought to evaluate the use of antimalarial drugs. Aim: The study was designed to evaluate the use of anti-malarial drugs in in-patient admission of medicine and pediatrics department at tertiary care teaching hospital. Methods: The data was obtained prospectively from 98 patients with antimalarial drugs over a period of 6 months. The evaluation was assessed based on age, pattern of malarial parasite, therapy and rationality of prescription. Results: The demographic details of patients admitted in hospital showed more male patients (60.52%) than children's (19.48%) and this reflects that the prevalence of the disease was higher among adult patients in this region during the study. Out of 98 patients prescribed with antimalarial drugs, only 46 patients showed malarial infection and 52 patients were diagnosed with non-malarial infection. In this study three drug combination therapy was prescribed more (30.61%) followed by two drugs combination. Rationality of antimalarial drug prescription was assessed by NVBDCP out of which 45.65% and 82.69% were irrational respectively. Conclusion: In this study it was found that inappropriate use of antimalarial drugs was higher among patients with Plasmodium falciparum and non-malarial patients. Cost of therapy was very high and thus it contributed to the economic burden on patients. Irrational prescriptions were high which indicated non-adherence to guidelines. Hence it concludes that educating the health professional for rational drug use as well as reducing the cost of therapy is essential.
INTRODUCTION

Malaria is a tropical disease transmitted by the female Anopheles mosquito of which
Anopheles gambiae is the most efficient vector. It is caused by infection by the protozoan parasite of the genus plasmodium, is a disease of global importance. 2 Malaria is a major cause of morbidity and mortality in the developing world. 3 It is a public health problem in more than 90 countries. Each year, between 300 and 500 million new cases are reported worldwide. 4 The global tally of malaria in 2015 was 212 million cases and 4, 29,000 deaths. According to the report fewer than half of the 91 malaria affected countries and territories are on track to achieve the 2020 milestone of a 40% reduction in case incidence and mortility. 15 WHO now recommends that treatment policies for falciparum malaria in all countries experiencing resistance to monotherapies such as chloroquine, sulphadoxinepyrimethamine and amodiaquine, should be combined preferably with those containing an artemisinin derivative. 5 Artemisinin also known as Qinghaosu and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for Plasmodium falciparum malaria, artemisinin is a sesquiterpene lactone.
India has the largest population in the world at risk of malaria, with 85% living in malarious zones.
7 Around 1.5 million confirmed cases are reported annually by the National Vector Borne Disease Control Programmed (NVBDCP), of which about 50% are due to Plasmodium falciparum. 8 In recent studies, chloroquine-resistant Plasmodium falciparum malaria has been observed with increasing frequency across the country.
9 Karnataka is located in western side of India, in the southern peninsular region. Since many years, the highest incidence in Karnataka were recorded in regions of Bijapur, Bagalkot, Raichur, Kolar, Bellary, Dakshina kannada and Mandya district which together accounted for more than 60% of malaria cases.
14 With this above background and Bagalkot is one of endemic city in Karnataka thus this study aims to evaluate antimalarial drugs use in S.N. Medical College and HSK Hospital, Bagalkot with specific aims to assess rationality of utilization of anti-malarial drugs, to assess potential interaction of antimalarial drugs with other prescribed drugs and to evaluate cost of anti-malarial drugs prescribed.
OBJECTIVES
• To assess rationality of anti-malarial drugs use.
• To assess potential interaction of anti-malarial drugs with other prescribed drugs.
• To evaluate cost of anti-malarial drugs prescribed.
METHODS
Study Design
This was a prospective hospital based observational study.
Study Location
This study was conducted in general medicine and Pediatrics Departments of S.N Medical College and HSK Hospital and Research Center Bagalkot. It is a multispecialty tertiary care teaching hospital with different specialties and super specialties. HSK Hospital provides primary and specialized health care facilities to people in and around Bagalkot district.
Study criteria
Inclusion criteria
• Patients diagnosed with malaria.
• Patients of all age group of either sex.
• Patients receiving anti-malarial drugs.
Exclusion criteria
• Patients attending outpatient department.
Study procedure
Personal visit made on daily basis to general medicine ward and paediatric wards to identify the patients who were diagnosed with malaria. Patient demographic details like name, age, sex, In Patient Department Number (IPD no), weight was noted in specially designed patient data collection form. Clinical history, diagnosis, laboratory investigations and treatment regimen of the patients and discharge medications were recorded daily in-patient data collection form. Treatment chart of the patients were reviewed daily to evaluate type of treatment regimen. Name of drug, dose, frequency, duration and cost of treatment was noted in patient data collection form. Further data were analysed for the anti-malarial drugs usage according to guidelines for the diagnosis and treatment of malaria (2011). Potential drug-drug interactions in the treatment regimen were assessed using Micromedex-2.0.
Cost benefit analysis 1. The average number of drug and I.V injection of antimalarial drugs prescribed for patients was calculated by using the below formula 
RESULTS AND DISCUSSION
Malaria is one of the major public health problems of the country. Prompt and effective treatment is important for preventing the transmission of malaria. In view of this we studied drug use of antimalarial in malaria patients. Drug use indicator as defined by WHO has provided easy and convenient measures to assess optimal drug use in health facilities. A total of 98 subjects were assessed for drug evaluation of antimalarial for 6 months of study period. The socio-demographic details of the study participants are represented in Table 1 and the result shows male predominance (60.52%) in antimalarial usage. The antimalarial are prescribed highly in the age group of 31-45 years (21.58%) which was like previous studies conducted in various areas 10, 11 and this reflects that the prevalence of the disease was higher among adult patients in this region during the study. During the study, out of 98 subjects prescribed with antimalarial drugs, 46 subjects showed malarial infection and 52 patients were diagnosed with non-malarial infection and in 46 malarial cases, 78.78% of patients were serum positive for Plasmodium falciparum and 21.22% were with Plasmodium vivax and mixed type of infection. This indicated that Plasmodium falciparum is more common in this area of Karnataka for malarial infection. This report was like the previous study. Table 2 . The major prescription of antimalarial agents was Artesunate (14.4%), Artesunate/ Sulfadoxine/Pyrimethamine (19.70%), Artemether/ Lumefantrine (17.42%), and Chloroquine (12.12%) and others 2 to 8% were observed. Data reported in Table 3 .
Data reported in
The Artesunate when prescribed alone lead to the development of resistance according to national vector borne disease control programme (NVBDCP).
NVBDCP recommended that Artesunate should be given in combination with Sulfadoxine/Pyrimethamine or lumefantrine. In this study three drug combination therapy was superior (30.61%) by two drugs combination. In the combination therapy, almost all contains artemisinin derivatives which was in accord with guidelines for diagnosis and treatment of malaria and a similar study was done previously. 13 Data reported in Table 4 . 2.17 % of prescriptions showed potential drugdrug interaction of artemisinin derivatives in malarial patients and 13.46% among non-malarial patients. Data reported in Table 5 and 6.
Rationality of antimalarial drug prescription was assessed by NVBDCP. During the study we observed that 46 malarial infection patients were prescribed with antimalarial drugs and out of these 45.65% were irrational prescriptions and out of 52 non-malarial patients, it was 82.69%. This showed that antimalarial drugs were prescribed more among the non-malarial infection patients. Therefore, there is a great need to educate health care workers. Data reported in Table 7 .
After evaluating this study, the prescribing indicators showed 44.879% of the prescribed I.V. injections increased the cost of prescription as injections are costlier then oral therapy. Not only the drug efficiency but also the cost of the drug is a major component in the drug utilization study. As in our study drug cost on injection was 86.51% out of total cost which indicated artemisinin derivatives were used more because these are available as I.V preparations and are much more expensive than conventional antimalarial drugs. This result was comparable with the study done in Gujarat.
12
Data reported in Table 8 and 9 .
CONCLUSION
In this study it was found that inappropriate use of antimalarial drugs was higher among patients with Plasmodium falciparum and non-malarial patients. The Cost of therapy was very high and thus it contributed to the economic burden on patients. Irrational prescriptions were high which indicted non-adherence to guidelines. Therefore, it concludes that educating the health professional for rational drug use as well as reducing the cost of therapy is essential.
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